Scott J. Dylla
Publications by Year
Research Areas
Lung Cancer Research Studies, Cancer Cells and Metastasis, Neuroendocrine Tumor Research Advances, Peptidase Inhibition and Analysis, Cancer therapeutics and mechanisms
Most-Cited Works
- → Phenotypic characterization of human colorectal cancer stem cells(2007)2,197 cited
- → Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML(2004)1,487 cited
- → Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy(2008)582 cited
- → A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo(2015)565 cited
- → Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study(2016)544 cited
- → In Vivo Visualization of Embryonic Stem Cell Survival, Proliferation, and Migration After Cardiac Delivery(2006)497 cited
- → DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency(2009)397 cited
- → Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century(2013)185 cited
- → A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions(2017)154 cited
- → Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression(2017)129 cited